Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001202556 | SCV001373672 | uncertain significance | H syndrome | 2019-07-18 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated for this variant, and the functional significance of the affected amino acid(s) is currently unknown. This variant has not been reported in the literature in individuals with SLC29A3-related conditions. This variant is not present in population databases (ExAC no frequency). This variant, c.303_320dup, results in the insertion of 6 amino acid(s) to the SLC29A3 protein (p.Tyr102_Leu107dup), but otherwise preserves the integrity of the reading frame. |
Institute for Clinical Genetics, |
RCV003321807 | SCV004026222 | uncertain significance | not provided | 2021-07-19 | criteria provided, single submitter | clinical testing | PM2_SUP |
Yale Center for Mendelian Genomics, |
RCV001849483 | SCV002106998 | pathogenic | Dysosteosclerosis | 2021-07-01 | no assertion criteria provided | literature only |